allogene
An Associate Director, Regulatory Affairs at Allogene Therapeutics manages global regulatory interactions and submissions for clinical studies and marketing authorizations. The role involves defining regulatory strategies, leading cross-functional teams, and ensuring alignment with evolving regulatory expectations for cell and gene therapies.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2017
Allogene is a clinical-stage biotechnology company developing off-the-shelf AlloCAR T cell therapies using multiplex gene engineering and gene-editing to create allogeneic (ready-made) CAR T candidates. The company pairs a proprietary lymphodepletion approach with scalable, state-of-the-art manufacturing to optimize safety, durability, and broader patient access. Lead programs include cemacabtagene ansegedleucel (cema‑cel) for large B‑cell lymphoma (including frontline DLBCL), ALLO‑316 for renal cell carcinoma, and ALLO‑329 for autoimmune disease, alongside a broader pipeline. Allogene’s platform strategy aims to accelerate delivery of cell therapies by removing patient-specific manufacturing constraints.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for allogene.
22% above the average for this role
Regulatory Affairs Manager
Intuitive
Associate Director, Regulatory Affairs - CMC
PTC Therapeutics
Associate Director, Regulatory Affairs
AbCellera
Manager, Regulatory Affairs
Maze Therapeutics
Associate Director, Regulatory Affairs
Seaport Therapeutics
Director, Regulatory Affairs Strategy - Genetics Medicine
Regeneron Pharmaceuticals